Now IBM is back with Watson supposedly helping Novartis (mega-pharma concern) on something called "outcomes-based care in advanced breast cancer (1)." It seems the Watson supercomputer is supposed to "use real-world patient data and cognitive computing with aim of improving outcomes in advanced breast cancer (1)."
You will recall how the MD Anderson program was supposed to use Watson: "...OEA is able to generate dynamic patient case summary by interpreting structured and unstructured clinical data and suggest personalized treatment options with reasonably high accuracy. Live system evaluation of OEA is ongoing and application of OEA in clinical practice is expected to be piloted at our institution (2/24/17 post).”
How much money will get thrown into this project, another $62 million?
Speaking of money, oncology researchers are lamenting the fact that they ain't gettin' enough dough from the National Cancer Institute and that "America may be losing its edge in medical research (2)." Even more lamentable, apparently, is "I fear we are losing a generation of young, talented biomedical scientists.”
Oh really? So we need to spend even more money to get misleading test results (see post of 1/7/17), or so-called "precision medicine" that causes explosive cancer growth (see post of 4/17/17), or fancy "multi-gene" test panels that might prolong your life for less than a week (see post of 5/5/17) or clinical trials where about 100 studies are clearly statistically wrong (3), in which the data are either fraudulent or grossly mishandled?
In my opinion, America is unfortunately doing with biomedical "research" what it does with our education system: throwing enormous amounts of money at inferior products; we have the most expensive health-care in the world, but other places have people living longer at far lower costs; we have the most expensive education system in the world, but we produce an embarrassingly dismal product.
- Carlisle JB. Data fabrication and other reasons for non-random sampling in 5087 randomised, controlled trials in anaesthetic and general medical journals. doi:10.1111/anae.13938.